PDCD1 and hepatocellular carcinoma: Several researchers have discovered that blockers of cytotoxic T lymphocyte-associated antigen 4, programmed cell death-ligand 1, and programmed cell death-1 elicit anti-cancer effects on HCC cells [17–19].